For the Quarter Ending September 2025
North America
• In United States, Sertraline Hydrochloride Price Index rose in Q3 2025, driven by robust pharmaceutical demand and rising input costs.
• Sertraline Hydrochloride production costs increased in Q3 2025, influenced by a 3.0% CPI rise in September and higher energy prices.
• Demand for psychotropic medications remained robust in Q3 2025, supported by strong overall pharmaceutical product demand.
• Demand outlook is positive, bolstered by a 5.42% retail sales increase and 4.3% unemployment rate in September 2025.
• Rising producer-level costs, indicated by a 2.6% PPI increase in August 2025, impacted Sertraline Hydrochloride manufacturing expenses.
• US natural gas prices experienced an uptick during Q3 2025, contributing to increased energy feedstock costs for chemical production.
• Weakening consumer confidence, declining to 94.2 in September 2025, signals bearish future out-of-pocket healthcare spending.
• US pharmaceutical exports declined in July 2025, while imports edged up, influencing domestic supply dynamics and chemical overcapacity.
Why did the price of Sertraline Hydrochloride change in September 2025 in North America?
• Rising production costs, evidenced by a 2.6% PPI increase in August 2025, pressured Sertraline Hydrochloride prices upward.
• Robust demand for psychotropic medications in Q3 2025 provided upward price support despite broader chemical oversupply.
• Increased energy costs for chemical manufacturers in Q3 2025 contributed to higher overall manufacturing expenses.
APAC
• In China, the Sertraline Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices and manufacturing contraction.
• Sertraline Hydrochloride production costs faced downward pressure in Q3 2025, as producer prices decreased by 2.3% in September 2025.
• Petrochemical feedstock costs, including benzene, remained stable in Q3 2025, contributing to steady input expenses.
• Demand for Sertraline Hydrochloride was supported by China's government action plan for health consumption in 2025.
• China's pharmaceutical industry saw growth in 2025, driven by an aging population and rising healthcare demands.
• Retail sales increased by 3.0% in September 2025, indirectly supporting healthcare spending and consumer access.
• Industrial production grew by 6.5% in September 2025, indicating a stable supply chain for pharmaceutical manufacturing.
• Global chemical overcapacity, particularly from China, tightened margins in Q3 2025, suggesting continued price pressure.
Why did the price of Sertraline Hydrochloride change in September 2025 in APAC?
• Producer Price Index decreased by 2.3% in September 2025, reducing Sertraline Hydrochloride manufacturing input costs.
• Consumer Price Index decreased by 0.3% in September 2025, indicating deflationary pressures on overall market pricing.
• Global chemical overcapacity, especially from China, contributed to tightened margins for Sertraline Hydrochloride in Q3 2025.
Europe
• In Germany, the Sertraline Hydrochloride Price Index rose quarter-over-quarter, influenced by strengthening aromatic hydrocarbon markets in 2025.
• Sertraline Hydrochloride production costs faced upward pressure from high European energy costs during Q3 2025.
• Demand for Sertraline Hydrochloride was supported by Germany's growing pharmaceutical market and chronic disease prevalence in Q3 2025.
• European chemical output declined in 2025, tightening Sertraline Hydrochloride supply and its precursors.
• Germany's industrial production decreased 1.0% year-over-year in September 2025, impacting upstream chemical supply.
• Producer prices decreased 1.7% year-over-year in September 2025, mainly due to lower energy prices.
• The Manufacturing Index for Q3 2025 was contracting, indicating a broader German manufacturing sector slowdown.
• Consumer Price Index increased 2.4% year-over-year in September 2025, suggesting rising operational expenses.
• Stable unemployment at 6.3% in September 2025 supported consistent healthcare spending and pharmaceutical demand.
Why did the price of Sertraline Hydrochloride change in September 2025 in Europe?
• Strengthening aromatic hydrocarbon markets and high energy costs pressured Sertraline Hydrochloride production expenses.
• Declining European chemical output and reduced EU27 capacity utilization tightened Sertraline Hydrochloride supply.
• Increased pharmaceutical demand, driven by an aging population, supported the Sertraline Hydrochloride price trend.
